It should be used within a specific timeframe as advised by your pharmacist, typically around 30 days
Pretreatment of RAW 264.7 macrophage cells with GHK-Cu has been shown to significantly decrease ROS levels induced by lipopolysaccharide (LPS), increase levels of SOD activities and total GSH, and decrease levels of TNF- and IL-6 production through the suppression of NF-B p65 and p38 MAPK signaling [22]
Do not drive after injection
On that test, an NNMT inhibitor plus an NAD+ precursor is at least internally coherent one addresses the drain, the other the supply while pairing 5-Amino-1MQ with an unrelated appetite-acting compound is not synergy, it is simply two separate interventions being run at once
Every fat-metabolism, NAD+, SIRT1 and lean-mass effect described above is preclinical (rodent or cell) only and should be read as a hypothesis, not an established human benefit
Protocol: - BPC-157: 300-500 mcg/day subcutaneous near the affected joint - TB-500: 2-2.5 mg twice per week subcutaneous (abdomen) - Duration: 6-8 weeks Best for: Acute joint injuries, post-surgical recovery, chronic joint pain that has not responded to single peptides
.png)
